Research Summary

I have significant experience conducting international, multi-center trials through established consortia, such as the Children's Oncology Group and the Pacific Pediatric Neuro-Oncology Consortium (PNOC), which I am leading. The current emphasis of PNOC lies in the development and rapid implementation of early phase clinical trials as well as to enhance access to innovative therapies through international collaborations including Europe, Israel, Egypt, Canada and Australia for children and young adults with brain tumors. I also lead a multi-site late effects cohort study (Rad ART) and collaborate with the Childhood Cancer Survivor Study for my late effect research.

Education

College, University of Hamburg, Germany  M.S.,  01/95,  Biochemistry
MD/PhD program, University of Hamburg,  M.D./Ph.D.,  01/03,  Chemistry
Harvard Medical School, Boston,  Intern,  01/05,  Pediatrics
Harvard Medical School, Boston,  Resident,  01/06,  Pediatrics
UCSF,  Clinical  Fellow,  06/09,  Child Neurology
UCSF,  Clinical  Fellow,  06/10,  Neuro-Oncology

Honors & Awards

  • 2019
    Eliminate Cancer Initiative Collaborative Team Science Award
  • 2018
    UCSF CTSI Yearlong Inquiry Fellowship Mentor of the Year Award
  • 2017
    UCSF Pediatric Fellow Mentorship Award
  • 2017
    UCSF Medical Center Exceptional Physician Award
  • 2015
    Research Award from the Matthew Larson Foundation
  • 2015
    Kure It Research Award
  • 2014
    Nominee of UCSF Medical Center's Exceptional Physician Award
  • 2013
    Award Winning Abstract Annual Meeting of the Society of Neuro-Oncology
  • 2012
    Research Award from the Matthew Larson Foundation
  • 2012
    KL2 CTSI Award
  • 2012
    Hellman Family Research Award
  • 2012
    University of California Cancer Coordinating Committee Award
  • 2011
    BRAIN SPORE Career Development Award
  • 2010
    Research Award from the Campini Foundation
  • 2008
    Chief Resident, Department of Neurology, UCSF
  • 2007
    Travel scholarship to attend the Annual Meeting of Neurology
  • 1999
    Center of Molecular Neurobiology (ZMNH) AACR research/travel award,Philadelphia, PA
  • 1999
    Bauer Stiftung Predoctoral Fellowship, Hamburg, Germany
  • 1998
    European Society of Neurobiology research/travel award, Berlin, Germany
  • 1997
    Center of Molecular Neurobiology (ZMNH) Predoctoral Fellowship, Hamburg,Germany

Selected Publications

  1. Barron T, Drexler R, Mochizuki A, Cantor E, Shamardani K, Woo PJ, Soni N, Tlais D, Franson A, Lyons S, Knowles T, Raber S, Mehta V, Quezada MA, Keough MB, Jahan SM, Vo LT, Castañeda EH, Taylor KR, Ni L, Kilian K, Wu SH, Ricklefs FL, Schüller U, Mueller S, Fisher PG, Campen CJ, Vogel H, Partap S, Kaila K, Koschmann C, Monje M. Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma. Nat Med. 2026 Sep 17. View on PubMed
  2. Khasraw M, Dun MD, Arrillaga-Romany I, Verhaak RGW, Bouffet E, Hansford JR, Singh K, Mueller S, Koschmann C, Wen PY. Point/Counterpoint: Dordaviprone for diffuse midline glioma - A landmark approval or a premature step? Neuro Oncol. 2026 Aug 01; 28(8):1829-1839. View on PubMed
  3. Montiel Equihua C, Baxter JS, Molenaar JJ, Areso I, Abbou S, Anderson J, Andre N, Ayrault O, Blanc P, Carpenter N, Daems S, D'Angiolella V, Danielson L, Donovan L, Durbin AD, Fouladi M, Gajjar A, Gilbertson R, Giraud G, Gottardo N, Hill R, Kearns P, Kool M, Lass G, Marino S, Mueller S, Newman S, Olson J, Patel S, Pfister SM, Rainsbury J, Ramaswamy V, Rutkowski S, Straathof K, Swartling FJ, Wechsler-Reya RJ, Pearson ADJ, Jenkinson D, Doz F, Clifford SC, LifeArc, Innovative Therapies for Children with Cancer (ITCC), Cancer Research UK, Cancer Grand Challenge Protect team. Paediatric therapeutic development workshop on medulloblastoma. Br J Cancer. 2026 Jul 09. View on PubMed
  4. Schreck KC, de la Fuente MI, Fat MJL, Maas SLN, Mulcahy Levy JM, Lombardi G, Perrault S, Petritsch CK, Aldape K, Chang SM, Duerinck J, Holdhoff M, Kazda T, Rhun EL, Minniti G, Mishra MV, Mueller S, Padovan M, Preusser M, Smits M, Weller M, Wen PY, van den Bent M, Geurts M. BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions. Neuro Oncol. 2026 Jun 08. View on PubMed
  5. Zapaishchykova A, Zielke J, Tak D, Climent Pardo JC, Mojahed-Yazdi R, Soto-Rivera CL, Liu KX, Saraf A, Ye Z, Wang W, Chen YH, Vajapeyam S, Mak RH, Mueller S, Nabavizadeh A, Wilson RL, Dieli-Conwright CM, Ligon KL, Haas-Kogan DA, Aerts HJWL, Poussaint TY, Benitez V, Chi SN, Kann BH. Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort study. Lancet Digit Health. 2026 07; 8(7):100973. View on PubMed
  6. Kuska J, Kostyra J, Pinot L, Egorov E, Jelveh N, Martinez Carrera LA, Zhang C, Khorkova S, Assenmacher M, Orentas R, Mueller S, Hidalgo JV. A clinical-grade automated platform for the manufacturing of CAR-γδ T cells for immunotherapy. Front Immunol. 2026; 17:1779035. View on PubMed
  7. Kotch C, Perreault S, Power P, Adams DJ, Aldape K, Avery RA, Bandopadhayay P, Capper D, de Blank P, Entz-Werle N, Fangusaro J, Hansford JR, Hawkins C, Jacques TS, Jones DT, Kann BH, Kranendonk ME, Levine A, Ligon KL, Martinez-Barbera JP, Meijer L, Milde T, Mueller S, Mulcahy Levy JM, Nakano Y, Packer RJ, Pfister S, Raabe E, Robison NJ, Tabori U, Yeo KK, Vinitsky A, Zhu Y, Fisher MJ, Hargrave D, Kilburn LB. Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma. Neuro Oncol. 2026 May 19. View on PubMed
  8. Abu-Arja MH, Rajabi Z, McGlynn MC, Ghebrelul RT, Zobeck M, Harasis S, Arora J, Zaghloul MS, Elhemaly A, Bertrand K, Gajjar A, Ronsley R, Cappellano AM, Dassi N, Czogala M, Graham RT, Knowles T, Mueller S, Fisher MJ, Finlay JL, Dhall G, Nagabushan S, Abdelbaki MS. Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. J Neurooncol. 2026 Apr 17; 177(3). View on PubMed
  9. Kondapavulur S, Bonnin DA, Perez S, Wu J, Perry A, Mueller S, Sun PP, Ho WS. Laser insterstitial thermal therapy followed by craniotomy for tumor resection for pediatric diffuse midline glioma: illustrative case. J Neurosurg Case Lessons. 2026 Apr 06; 11(14). View on PubMed
  10. Batsios G, Taglang C, Udutha S, Gillespie AM, Phoenix T, Mueller S, Venneti S, Koschmann C, Viswanath P. Lactylation fuels nucleotide biosynthesis and facilitates deuterium metabolic imaging of tumor proliferation in preclinical models of H3K27M-mutant gliomas. Sci Transl Med. 2026 Feb 11; 18(836):eadw0834. View on PubMed
  11. Tak D, Garomsa BA, Zapaishchykova A, Chaunzwa TL, Climent Pardo JC, Ye Z, Zielke J, Ravipati Y, Pai S, Vajapeyam S, Mahootiha M, Parker M, Pike LRG, Smith C, Familiar AM, Liu KX, Prabhu S, Arnaout O, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJ, Huang RY, Poussaint TY, Kann BH. A generalizable foundation model for analysis of human brain MRI. Nat Neurosci. 2026 Apr; 29(4):945-956. View on PubMed
  12. Chrysochoou D, Gandhi DB, Adib S, Familiar AM, Vunnava B, Varshochi S, Khalili N, Khalili N, Ware JB, Tu W, Jain P, Anderson H, Haldar S, Storm PB, Franson A, Prados M, Kline C, Mueller S, Resnick A, Vossough A, Davatzikos C, Nabavizadeh A, Kazerooni AF. AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors. NPJ Precis Oncol. 2026 Jan 13; 10(1):63. View on PubMed
  13. Mandzak M, Yang E, Zapaishchykova A, Chen YH, Heilbroner L, Zielke J, Tak D, Mojahed-Yazdi R, Mussa FR, Ye Z, Vajapeyam S, Benitez V, Salloum R, Chi SN, Sotoudeh H, Seidlitz J, Mueller S, Aerts HJWL, Poussaint TY, Kann BH. TissUnet: Improved extracranial tissue and cranium segmentation for children through adulthood. Imaging Neurosci (Camb). 2026; 4. View on PubMed
  14. Moon R, Mueller S, Varlet P. Intrinsic pontine tumors: Pathology of brainstem tumors and exploration of diffuse intrinsic pontine glioma. Handb Clin Neurol. 2026; 216:171-182. View on PubMed
  15. Zhu J, Tsoli M, Bertoldo J, Mueller S, Ziegler DS. A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma. Neurooncol Adv. 2026 May; 8(Suppl 2):ii41-ii58. View on PubMed
  16. Kann BH, Vossough A, Brüningk SC, Familiar AM, Aboian M, Linguraru MG, Yeom KW, Chang SM, Hargrave D, Mirsky D, Storm PB, Huang RY, Resnick AC, Weller M, Mueller S, Prados M, Peet AC, Villanueva-Meyer JE, Bakas S, Fangusaro J, Nabavizadeh A, Kazerooni AF, Response Assessment in Pediatric Neuro-Oncology (RAPNO) group. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art. Lancet Oncol. 2025 Nov; 26(11):e597-e606. View on PubMed
  17. Kazerooni AF, Familiar AM, Aboian M, Brüningk SC, Vossough A, Linguraru MG, Huang RY, Hargrave D, Peet AC, Resnick AC, Storm PB, Mirsky D, Yeom KW, Weller M, Prados M, Chang SM, Mueller S, Villanueva-Meyer JE, Bakas S, Fangusaro J, Kann BH, Nabavizadeh A, Response Assessment in Pediatric Neuro-Oncology (RAPNO) group. Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation. Lancet Oncol. 2025 Nov; 26(11):e607-e618. View on PubMed
  18. Duchatel RJ, Savary C, Germon ZP, Riley M, Ziegler DS, Mueller S, Jackson ER, Dun MD. Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomas. Neuro Oncol. 2025 Nov 01; 27(11):2789-2803. View on PubMed
  19. Kotch C, Gomes A, Schatz KS, Dombi E, Brown S, Gross AM, Alves M, Perreault S, Mueller S, Reddy AT, Romo C, Bornhorst M, Tonsgard J, Weiss BD, Widemann B, Fisher MJ. The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma. Hum Genet. 2025 Dec; 144(11-12):1199-1206. View on PubMed
  20. Erker C, Mynarek M, Simbozel M, Craig BT, Harrod VL, Cappellano AM, Cohen KJ, Lopez VS, Morales La Madrid A, Cacciotti C, Baroni L, Salloum R, Margol AS, Michaiel G, Aguilera D, Mazewski CM, Kline CN, Finlay JL, Abdelbaki MS, Murray JC, Dorris K, Crooks B, Ginn KF, Amayiri N, Tippelt S, Fleischhack G, Tonn S, Gerber NU, Lassaletta A, Hansford JR, Khan S, Gilheeney SW, Hoffman LM, Zapotocky M, Larouche V, Shah S, Ramaswamy V, Gajjar A, Perreault S, Mueller S, Hukin J, Cheng S, Wang ZJ, Matheson K, Bailey S, Bouffet E, Clifford SC, Robinson G, Dufour C, Rutkowski S, Lafay-Cousin L. Salvage therapies for first relapse of SHH medulloblastoma in early childhood. Neuro Oncol. 2025 Sep 17; 27(8):2158-2169. View on PubMed

Go to UCSF Profiles, powered by CTSI